What Is 21 CFR

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 21 CFR (Code of Federal Regulations Title 21) is the FDA's regulatory framework governing food, drugs, medical devices, and cosmetics in the U.S., established in 1938 following the Federal Food, Drug, and Cosmetic Act. It is enforced by the FDA and updated regularly to reflect scientific and technological advances.

Key Facts

21 CFR was established in 1938 following the passage of the Federal Food, Drug, and Cosmetic Act
The FDA enforces 21 CFR regulations across over 1,200 pages of federal rules
Title 21 regulates all FDA-approved drugs, including over 10,000 prescription and OTC products
Medical device classifications under 21 CFR range from Class I (low risk) to Class III (high risk)
The 2023 update to 21 CFR strengthened cybersecurity requirements for connected medical devices

Overview

21 CFR, or Title 21 of the Code of Federal Regulations, is the primary regulatory framework enforced by the U.S. Food and Drug Administration (FDA). It governs the manufacture, distribution, labeling, and safety of food, pharmaceuticals, medical devices, and cosmetics across the United States. Originally established in 1938, it has evolved to address modern health challenges and technological innovations.

The scope of 21 CFR spans over 1,200 pages and is divided into chapters and parts based on product type and regulatory function. It ensures public safety by setting standards for product testing, clinical trials, and post-market surveillance. Non-compliance can result in fines, product recalls, or criminal charges.

Part 111: Requires dietary supplement manufacturers to follow Current Good Manufacturing Practices (cGMP) to ensure product identity, purity, and strength.
Part 210 and 211: Sets cGMP standards for pharmaceuticals, mandating quality control in manufacturing, testing, and recordkeeping since 1978.
Part 807: Requires medical device manufacturers to register annually with the FDA and list all devices in commercial distribution.
Part 101: Regulates food labeling, including nutrition facts panels, allergen disclosures, and health claims approved by the FDA.
Part 58: Establishes Good Laboratory Practice (GLP) standards for non-clinical studies supporting research submissions to the FDA.

How It Works

21 CFR operates through a structured hierarchy of parts and subparts, each addressing specific regulatory domains. Compliance is mandatory for any company marketing regulated products in the U.S., and the FDA conducts inspections and audits to enforce standards.

Pre-Market Approval (PMA):Class III medical devices require PMA, a rigorous process involving clinical data submission and FDA review lasting up to 180 days.
Investigational New Drug (IND):IND applications must be filed before human clinical trials for drugs, allowing the FDA to monitor safety in phases I–III.
Current Good Manufacturing Practice (cGMP):cGMP regulations require facilities to maintain clean environments, validated processes, and thorough documentation to prevent contamination.
Adverse Event Reporting:Manufacturers must report serious adverse events within 30 days under MedWatch, enhancing post-market surveillance.
Labeling Compliance:All labels must be FDA-reviewed for accuracy, including dosage instructions, warnings, and ingredient lists to prevent consumer misinformation.
Inspection and Enforcement:Unannounced FDA inspections occur every 1–2 years, with Form 483 issued for observed violations leading to corrective actions.

Comparison at a Glance

Regulatory standards vary significantly across product types under 21 CFR, as shown in the table below.

Product Type	Regulatory Part	Approval Process	Inspection Frequency	Key Requirement
Prescription Drugs	21 CFR Parts 312, 314	NDA/BLA submission	Biennial	Clinical trial data submission
Medical Devices	21 CFR Parts 807, 814	510(k) or PMA	Every 2 years	Substantial equivalence or clinical evidence
Dietary Supplements	21 CFR Part 111	None (post-market)	Random	cGMP compliance
Food Additives	21 CFR Part 170	Premarket notification	Annual	GRAS or FDA approval
Cosmetics	21 CFR Part 700	None	As needed	Labeling and safety

The table highlights how 21 CFR tailors oversight based on risk level. While drugs and devices require pre-market approval, supplements and cosmetics are regulated post-market, relying more on manufacturer accountability and FDA enforcement actions when issues arise.

Why It Matters

21 CFR is foundational to public health protection, ensuring that products Americans use daily meet rigorous safety and efficacy standards. Its enforcement helps prevent contaminated, misbranded, or ineffective products from reaching consumers.

Ensures drug safety:Over 95% of FDA-approved drugs undergo clinical trials regulated under 21 CFR to verify safety and effectiveness before market entry.
Protects food supply:Mandated pathogen testing under Part 117 prevents outbreaks of E. coli and Salmonella in processed foods.
Supports innovation:Fast Track and Breakthrough Therapy designations under 21 CFR accelerate development of life-saving treatments.
Enables global trade:U.S. compliance with 21 CFR allows pharmaceutical exports valued at over $120 billion annually.
Reduces fraud:Strict labeling rules prevent false health claims, protecting consumers from misleading supplement marketing.
Improves recall response:Established reporting protocols allow the FDA to issue recalls within 48 hours of identifying a critical defect.

As medical technology and food science evolve, 21 CFR continues to adapt, maintaining trust in regulated products while balancing innovation and public safety.